| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 47 |
| 1 | PREDNISOLONE ORAL | 47 |
| 2 | PREDNISOLONE ORAL SOLUTION | 47 |
| 3 | BEVACIZUMAB | 46 |
| 4 | FLUOROURACIL | 41 |
| 5 | FLUOROURACIL CREAM, 0.5% | 41 |
| 6 | RIVAROXABAN | 35 |
| 7 | PEMBROLIZUMAB | 32 |
| 8 | CISPLATIN | 31 |
| 9 | FUROSEMIDE | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTEIN C CONCENTRATE HUMAN | 1 | 0.0125 |
| 1 | CHLORHEXIDINE GLUCONATE ORAL RINSE | 1 | 0.0119 |
| 2 | OLOPATADINE HCL | 2 | 0.0055 |
| 3 | SODIUM ACETATE | 1 | 0.0035 |
| 4 | PSYLLIUM HUSK | 4 | 0.0030 |
| 5 | INFLUENZA A VIRUS, INFLUENZA B VIRUS, HISTAMINUM HYDROCHLORICUM, ACONITUM NAP., ARALIA QUINQUEFOLIA, ARSENICUM ALB., BAPTISIA, BRYONIA, CINCHONA, EUPATORIUM PERF., GELSEMIUM, IPECAC., KALI CARB., NUX VOM., PHOSPHORUS, RHUS TOXICODENDRON, ECHINACEA | 1 | 0.0029 |
| 6 | CLEVIDIPINE | 1 | 0.0027 |
| 7 | PONESIMOD | 1 | 0.0023 |
| 8 | CHLORPROMAZINE HYDROCHLORIDE | 2 | 0.0021 |
| 9 | AFICAMTEN | 1 | 0.0020 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 6 | 0.0010 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 5 | 0.0008 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 5 | 0.0006 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 56 | 0.0006 |
| 6 | Sulfone [EPC] | 6 | 0.0006 |
| 7 | Anti-coagulant [EPC] | 2 | 0.0005 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 25 | 0.0005 |
| 9 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |